Effective: August 1, 2015 Non-QHP Commercial and TPA Plans 5 Tier Formulary (List of Covered Drugs)

Effective: August 1, 2015 Non-QHP Commercial and TPA Plans 5 Tier Formulary (List of Covered Drugs) What is the Drug List? Also called a formulary by doctors and pharmacists, the Drug List is an extensive list of safe and effective, FDA-approved, brand name and generic prescription drugs used to treat the most common medical conditions. The Health First Pharmacy and Therapeutics Committee (P&T), a panel of physicians and pharmacists, developed our Drug List and updates it regularly. The list includes quality drugs available to you at reasonable cost. Only those medications that have successfully passed federally required clinical testing and evaluation and have been proven effective are included. The Pharmacy and Therapeutics Committee reviews and evaluates all available literature about a drug when updating the list. About Tiers Most covered prescription drugs will be categorized into one of five tiers. The cost of drugs varies widely, even though several different medications may be used to treat the same condition. What you pay for the prescription depends upon what tier the drug is listed in. Health First offers many benefit plans that can vary in coverage for each tier. Details about your specific benefit for each tier are included in the Health First Summary of Benefits. Prescriptions that exceed a 30 day supply will default to a 90 day supply copay (this does not apply to coinsurances). For coinsurances, you will always pay a percentage of the total cost after the applicable deductible is met. Tier 1 Preferred Generic Drugs Tier 2 Non-Preferred Generic Drugs Tier 3 Preferred Brand Name Drugs and some generics Tier 4 Non-Preferred Brand Name Drugs and some generics (some plans may be limited to a 30-day supply) Tier 5 Specialty Drugs (Must obtain from Health First Family Pharmacy and some plans may be limited to a 30-day supply. For members living outside the state of Florida an exception will be considered to allow the member to obtain the medication at another pharmacy. Please contact our Customer Service Department to initiate this process.) NCS No Cost Share Generic drugs are prescription drugs that are identified by their chemical name. When the patent has expired on a brand name drug, the FDA permits new manufacturers to create an equivalent of the brand name drug and make it available to the public. Generally, more than one manufacturer will create generic versions, although often the 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 1

same pharmaceutical firm that produces the brand name drug also makes the generic version. This prompts competitive pricing of the generic version and usually results in a less expensive drug. The Drug List is subject to change In order to continue to offer a safe and cost effective selection of prescription drugs, Health First periodically makes changes to the Drug List. These changes may include removing medications, adding restrictions, and/or covering a drug at a higher tier. Updated formularies are posted to the website as changes are made. The following list represents some of the most common scenarios in which changes to drug coverage will occur: Throughout the year, new medications are approved by the FDA. It is the policy of Health First that new drugs will be excluded for 6 months from the date of FDA approval, during which time the Health First Pharmacy and Therapeutics Committee can review the drug for safety and efficacy. The Drug List may change when a medication is withdrawn from the market due to safety reasons or if it becomes available over-thecounter (OTC). At the time that a medication on the Health First Drug List becomes available OTC, it may be excluded from coverage from that point forward. When a brand-name prescription drug loses its patent and the equivalent generic form is added to the Drug List, the brand-name drug may be moved to the highest non-specialty drug tier, which is generally Tier 4, or removed from the formulary. This formulary is current as of August 1, 2015. To get updated information about covered drugs, please visit our Web site at myhfhp.org or call or call Customer Service toll-free at 1.855.443.4735 (TTY/TDD relay: 1.800.955.8771) Monday through Friday from 8 a.m. to 6 p.m. Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: Prior Authorization: Health First requires you and/or your physician to get prior authorization for certain drugs. This means that you will need to get approval from us before you fill your prescriptions. In order for the plan to pay for these drugs, the physician ordering the prescription is required to submit all medical information to Health First documenting the medical necessity. These drugs are identified in the Drug List. Step Therapy: In some cases, Health First requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, we may not cover drug B unless you try Drug A first. If Drug A does not work for you, we will then cover Drug B. Please see the reference table on page 6 for a complete listing of the drugs which currently require step therapy. Quantity Limits: For certain drugs, Health First limits the amount of the drug that Health First will cover. For example, Health First provides 30 tablets per prescription for Jalyn. This may be in addition to a standard one month or three month supply. How can I make the most of my prescription drug benefit? Prescription drug costs continue to rise every year and can represent a significant part of your healthcare expenses. Health First can help you pay for your medications by sharing the cost with you and providing substantial discounts for medications you purchase. To help you manage your drug costs, here are some money-saving tips to consider: Use Tier 1 generic medications whenever possible. Generic drugs are the chemical equivalent of brand-name drugs, and are just as effective in most cases. If you take generic drugs you will generally pay less, so talk to your doctor about switching to a generic equivalent of any brand-name you are taking if it is appropriate. In addition, many of our prescription drug riders include a $2 copayment for Tier 1 generic drugs ensuring affordable access to many commonly prescribed medications. Please see the list of drugs below to determine which drugs are included in Tier 1. See if your prescription pills can be split in half For some medications, pills may be available in different strengths but still have the same price. If you need one of these select medications, your doctor may be able to write your prescription so that you can get your pills at double strength, but half of the number of pills you d normally need, and you d only pay half of the regular price. Then you d split them in half, so you d get the proper dose saving up to 50 percent of the cost! The drugs that may be eligible for the Pill-Splitting program are marked with the symbol (1/2) on the drug list, so review this information with your doctor if your drug qualifies. 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 2

What if my drug is not on the Formulary? If your drug is not included in this formulary, you should first contact Customer Service and confirm that your drug is not covered. If you learn that Health First does not cover your drug, you have two options: You can ask Customer Service for a list of similar drugs that are covered by Health First. When you receive the list, show it to your doctor and ask him or her to prescribe a similar drug that is covered by Health First. You can ask Health First to make an exception and cover your drug. See below for information about how to request an exception. If Health First approves you or your physician s request for an exception to the Health First formulary the approved drug will be covered at the Tier 4 cost share. If the cost of the medication is greater than $500 per month it will be covered at the Tier 5 or Specialty Tier. Excluded drugs Health First does not provide coverage for all drugs. In addition to the drugs marked excluded in this drug list, newly FDA approved drugs are not covered unless the P & T Committee in its sole discretion approves these drugs for coverage. Health First will automatically exclude a particular drug if a generic version becomes available and an entire class of drugs if a particular drug within that class becomes available over the counter. The following are NOT covered by HFHP: Compounded drugs Cosmetics or any drugs used for cosmetic purposes (such as Retin- A, Rogaine, Topical Minoxidil, and Vaniqa) Diabetic supplies, blood glucose monitors and test strips other than those manufactured by Abbott under the product name Freestyle, Precision, and test strips Erectile dysfunction drugs (such as Viagra) Infertility drugs (such as Clomid) Injectables (except insulin, Imitrex, and those requiring prior authorization) Multivitamins and nutritional supplements (except prescription prenatal vitamins) Nicotine products Nonprescriptive supplies or substances Oral and topical antifungals for onychomycosis (such as Lamisil, Sporanox, and Penlac) Over-the-counter (OTC) medications (such as Lotrimin, Zantac 75, Pepcid AC or their generic formulations), or any drug for which a similar over-the-counter version is available All new drugs approved by the FDA will be excluded from the preferred drug list/formulary unless HFHP s Pharmacy and Therapeutics Committee, in its sole discretion, decides to waive this exclusion for a particular drug. Support garments Syringes, needles, or other disposable supplies (except those used with insulin) 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 3

Health First Health Plans Formulary The formulary that begins on the next page provides coverage information about some of the drugs covered by Health First. If you have trouble finding your drug in the list, turn to the Index that begins on page 81. The first column of the chart lists the drug name. Brand name drugs are capitalized (e.g., PRADAXA) and generic drugs are listed in lower-case italics (e.g., lisinopril). The information in the Notes column tells you if Health First has any special requirements for coverage of your drug. Specialty Pharmacy (SP): Must obtain from Health First Family Pharmacy and some plans may be limited to a 30-day supply. For members living outside the state of Florida an exception will be considered to allow the member to obtain the medication at another pharmacy. Please contact our Customer Service Department to initiate this process. Prior Authorization (PA): Health First requires you or your physician to get prior authorization for certain drugs. This means that you will need to get approval from Health First before you fill your prescriptions. If you don't get approval, Health First may not cover the drug. Quantity Limit (QL): Quantity Limits may also be listed. (For example, 30/30 days would mean your coverage of this drug is limited to 30 pills every 30 days.) Prescriptions written for more than the suggested Quantity Limits will only be honored up to the listed amount. Step Therapy (ST): In some cases, Health First requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, Health First may not cover drug B unless you try Drug A first. If Drug A does not work for you, Health First will then cover Drug B. Pill Splitting (1/2): You may be able to split these pills in half. Begin by asking your doctor if pill-splitting is right for you. If so, ask your doctor to write your prescription for half the number of pills and double the strength you normally need. For example, instead of 30 pills of 20 mg, you d get a prescription for 15 pills of 40 mg. Then you (or the pharmacy) can split them in half for the correct dose. This way, you save 50 percent of the cost. Call our Customer Service Department for details. Maintenance Drug (): You may be taking these drugs on a long-term basis. Maintenance medications are generally those used to treat chronic conditions and long-term conditions. **Some exceptions may apply (i.e. certain medications used for ADHD, asthma/copd rescue, acute pain, and acute infections). For information about a specific drug not listed, please call Customer Service toll-free at 1.855.443.4735 (TTY/TDD relay: 1.800.955.8771) Monday through Friday from 8 a.m. to 6 p.m. 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 4

Preventive Care Medications: $0 Cost-share Medications and Products The Affordable Care Act (ACA), commonly known as health care reform, was signed into federal law in 2010. The ACA requires private insurers to cover certain preventive services without any patient cost-sharing (i.e., copayments, coinsurance and deductible) when they are delivered by a network provider. The Department of Health and Human Services (HHS) has recognized several recommending bodies (e.g., United States Preventive Services Task Force [USPSTF], Advisory Committee on Immunization Practices [ACIP], and Health Resources and Services Administration [HRSA]) who have identified several medication categories that fall within the preventive health mandate. The following products, prescription medications and specific over-the-counter (OTC) medications (notated in Tier NCS throughout this formulary) are available to our members at no ($0) cost-sharing when: Prescribed by a health care professional (all prescription and OTC medications will require a prescription) Age and/or gender appropriate U.S. Preventive Services Task Force A & B Recommendation Medications and Supplements Aspirin (325 mg tablets, 81 mg chewable tablets) Vitamin D (50000 unit capsules) Iron (Ferrous Sulfate, 325 mg tablets) Folic Acid (1 mg tablets) Pediatric Multiple Vitamins w/ Fluoride (1 mg chewable tablets, 0.5 mg/ml solution) Pediatric Multiple Vitamins w/ Iron (15 mg chewable tablets, 10 mg/ml drops Sodium Fluoride (1 mg tablets, 1 mg chewable tablets) Tobacco Cessation Medications If you need help to quit smoking or using tobacco products, these preventive medications will be available at $0 cost-share. To qualify, you must be: 18 years of age or older, Receiving counseling and have a prescription from a health care provider, Up to two, 3-month treatment courses are covered at no cost each year. Any additional treatment may be subject to a cost-share. Covered treatment regimens include: Nicotine replacement therapy (nicotine patches, nicotine gum, nicotine lozenges, nicotine inhaler, nicotine nasal spray) Chantix Generic Zyban (bupropion) Breast Cancer Preventive Medications For women who are at increased risk for breast cancer but who have not had breast cancer, medications such as tamoxifen or raloxifene are available at $0 cost-share. If you are 35 years of age or older and have not had breast cancer, talk to your doctor about your risk. If appropriate, your doctor may offer to prescribe one of these risk-reducing medications. Your doctor can then submit a Prior Authorization request to get the medication approved at $0 cost-share if coverage criteria are met. 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 5

Contraceptive Methods Oral contraceptives combined: NECON, NORTREL, WERA 0.5-35 MG-MCG ALYACEN, CYCLAFEM, DASETTA, NECON, NORTREL 21, NORTREL 28, PRIMELLA 1-35 MG-MCG GILDESS, JUNEL, LARIN, MICROGESTIN, NORETHINDRONE-ETHINYL ESTRADIOL 1-20 MG-MCG GILDESS, JUNEL, LARIN, MICROGESTIN 1.5-30 MG-MCG CRYSELLE, ELINEST, LOW-OGESTREL 0.3-30 MG-MCG ESTARYLLA, MONO-LINYAH, MONONESSA, NORGESTIMATE-ETHINYL ESTRADIOL, PREVIFEM, SPRINTEC 0.25-35 MG-MCG GILDESS FE, JUNEL FE, LARIN FE, MICROGESTIN FE, NORETHINDRONE-ETHINYL ESTRADIOL FE 1-20 MG-MCG GILDESS FE, JUNEL FE, LARIN FE, MICROGESTIN FE 1.5-30 MG-MCG AZURETTE, DESOGESTREL-ETHINYL ESTRADIOL, KARIVA, PIMTREA, VIORELE 0.02-0.01 MG (21/5) ALYACEN, CYCLAFEM, DASETTA, NECON, NORTREL, PRIMELLA 7/7/7 NORGESTIMATE-ETH ESTRADIOL, TRI-ESTARYLLA, TRI-LINYAH, TRINESSA, TRI-PREVIFEM, TRI-SPRINTEC Oral contraceptives extended/continuous use: INTROVALE, JOLESSA, LEVONORGESTREL-ETHYINYL ESTRADIOL, QUASENSE 0.15-0.05 MG (91-DAY) Oral Contraceptives progestin only CAMILA, DEBLITANE, ERRIN, HEATHER, JENCYCLA, JOLIVETTE, LYZA, NORA-BE, NORETHINDRONE, NORLYROC, SHAROBEL 0.35 MG Injection: MEDROXYPROGESTERONE 150 MG INJ Patch: XULANE PATCH (generic OrthoEvra) Vaginal Ring: NUVARING (Vaginal Ring) Emergency Contraception-Progestin: LEVONORGESTREL 0.75 MG Emergency Contraception- Ulipristal Acetate: ELLA Implantable Rod: IMPLANON/NEXPLANON IUD Copper: PARAGUARD 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 6

Contraceptive Methods Continued IUD Progestin: MIRENA, SKYLA Diaphragm with Spermicide: OMNIFLEX DIAPHRAM Sponge with Spermicide: TODAY SPONGE Cervical Cap with Spermicide: FEMCAP, PRENTIF Female Condom: FC FEMALE CONDOM Spermicide alone: NONOXYNOL-9 GEL *** The FDA Birth Control Guide additionally lists sterilization surgery for men and male condoms, but the HRSA Guidelines exclude services relating to a man s reproductive capacity. If you have any questions regarding your eligibility for preventive care medications and preventive contraceptive coverage, please contact your employer or call Customer Service toll-free at 1.855.443.4735 (TTY/TDD relay: 1.800.955.8771) Monday through Friday from 8 a.m. to 6 p.m. 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 7

Step Therapy Reference Table Step Therapy Reference Table Drug Name Drug that must be tried first Drug Name Drug that must be tried first ACTONEL alendronate PATANASE Veramyst or fluticasone nasal AVANDIA Any pioglitazone containing product RELPAX sumatriptan AXERT sumatriptan RENAGEL calcium acetate 667 mg CELEBREX/Celecoxib meloxicam RENVELA calcium acetate 667 mg CYCLOSET ESZOPICLONE Any metformin containing product Zolpidem IR RIZATRIPTAN; RIZATRIPTAN ODT sumatriptan EURAX CREAM EXELDERM FOSRENAL permethrin AND lindane topical products ketoconazole AND clotrimazole topical products calcium acetate 667 mg TOLAZAMIDE TOLBUTAMIDE Any glipizide containing product AND any glimepiride containing product Any glipizide containing product AND any glimepiride containing product FROVA sumatriptan TREXIMET sumatriptan GLYSET Any metformin containing product ULORIC allopurinol LEVATOL LYRICA METFORMIN SR24 HR OSMOSTIC NARATRIPTAN NASONEX Any Tier 1 or Tier 2 formulary beta blocker gabapentin Trial of metformin ER (generic Glucophage XL) sumatriptan Veramyst or fluticasone nasal VIIBRYD WELCHOL ZOLMITRIPTAN; ZOLMITRIPTAN ODT Trial of any two (2) of the following drugs: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, mirtazapine, paroxetine, sertraline, trazodone, venlafaxine cholestyramine or colestipol sumatriptan OMNARIS Veramyst or fluticasone nasal ZOMIG NASAL sumatriptan OXISTAT ketoconazole AND clotrimazole topical products 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 8

Covered Generic Drugs The following brand name drugs have generic alternatives that may be a cost savings to you Brand Name Drug Brand Tier Generic Alternative CRESTOR atorvastatin, simvastatin DEXILANT omeprazole, pantoprazole BENICAR losartan Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits Tamiflu Tiering Change T5 (SP) Change made 12/1/2014; Effective 1/1/2015 N/A Humulin R U-500 Addition - T5 Change made 12/3/2014; Effective 1/1/2015 QL Latuda 60mg and 120mg Prednisolone Sodium Phosphate 1% Opthalmic Solution Addition - 2/20/2015 Tiering Change 3/2/2015 Grastek Addition - 3/2/2015 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 9

Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits Ragwitek Addition - 3/2/2015 Zonitivy Addition - 3/2/2015 Glyxambi Addition - 3/2/2015 Zyflor CR PA Added - - 3/5/2015 Viibryd Step Therapy Added - - 3/5/2015 Clorazepate Pen Needles PA Removed - - 3/5/2015 QL Change - - 3/19/2015 Increase QL to 200 needles per 31 days Linzess Addition - 3/20/2015 Brintellix Benicar/Benicar HCT Addition - 3/20/2015 Change - - 4/1/2015 Removed step therapy requirement Vyvanse 10 mg Addition - 4/27/2015 Pulmicort Suspension Drug Removed - - 5/4/2015 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 10

Formulary Changes Celecoxib Drug Name Change Previous Tier New Tier Effective Date Addition - 5/4/2015 New Requirements/ Limits Step therapy through meloxicam required Asmanex HFA Addition - 5/11/2015 QL 13 GM per 30 days Creon 36,000 Addition - 6/9/2015 Felbamate Change - - 6/16/2015 Removed step therapy requirement Ella TABLET 30 MG ORAL Addition - NCS 6/16/2015 NuvaRing RING 0.12-0.015 MG/24HR VAGINAL Addition - NCS 6/16/2015 Implanon/Nexplanon (share same GPI) Addition - NCS 6/16/2015 Paragard Intrauterine Copper INTRAUTERINE DEVICE INTRAUTERINE Mirena INTRAUTERINE DEVICE 20 MCG/24HR INTRAUTERINE Skyla INTRAUTERINE DEVICE 13.5 MG INTRAUTERINE Addition Addition Addition - NCS 6/16/2015 - NCS 6/16/2015 - NCS 6/16/2015 Omniflex Diaphragm DIAPHRAGM VAGINAL Addition - NCS 6/16/2015 Prentif/FemCap Cavity-Rim Cerv Cap DEVICE 22 MM VAGINAL Prentif Cavity-Rim Cerv Cap DEVICE 25 MM VAGINAL Addition Addition - NCS 6/16/2015 - NCS 6/16/2015 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 11

Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits Prentif Cavity-Rim Cerv Cap DEVICE 28 MM VAGINAL Prentif Cavity-Rim Cerv Cap DEVICE 31 MM VAGINAL Addition Addition - NCS 6/16/2015 - NCS 6/16/2015 FemCap DEVICE 30 MM VAGINAL Addition - NCS 6/16/2015 FemCap DEVICE 26 MM VAGINAL Addition - NCS 6/16/2015 Today Sponge 1000 MG VAGINAL Addition - NCS 6/16/2015 FC2 Female Condom/FC Female Condom Addition - NCS 6/16/2015 Nonoxynol-9 Gels Addition - NCS 6/16/2015 testosterone cypionate inj 100mg/ml Addition - 6/16/2015 PA testosterone cypionate inj 200mg/ml Addition - 6/16/2015 PA testosterone enanthate inj 200mg/ml Addition - 6/16/2015 PA Remicade Drug Removed T5 (SP) - 7/13/2015 Vascepa Addition - 8/1/2015 Breo Ellipta 200-25mcg Addition - 8/1/2015 aripiprazole tablet Addition - 8/3/2015 PA fluoxetine 40mg capsule Addition - T1 8/10/2015 QL (62 EA per 31 amlodipine-benazepril capsule Addition - 8/10/2015 QL (31 EA per 31 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 12

Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits acyclovir 5% ointment Addition - 8/10/2015 QL (60 GM per 31 metronidazole 1% external Addition - 8/10/2015 tacrolimus ointment Addition - 8/10/2015 PA amlodipine-valsartan Addition - 8/10/2015 amlodipine-valsartan-hctz Addition - 8/10/2015 tretinoin microsphere external Addition - 8/10/2015 butalbital-aspirin-caffeine-codeine capsule Addition - 8/10/2015 calcipotriene-betamethasone ointment Addition - 8/10/2015 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 13

ADHD/ANTI-NARCOLEPSY/ANTI-OBESITY/ANOREXIANTS AMPHETAMINES-AMPHETAMINE MIXTURES ADDERALL XR ORAL CAPSULE EXTENDED RELEASE 24 HOUR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) AGENTS-ADHD AGENT - SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR STRATTERA ORAL CAPSULE STIMULANTS - MISC.-STIMULANTS - MISC. amphetaminedextroamphetamine oral tablet DAYTRANA TRANSDERMAL PATCH AMPHETAMINES-AMPHETAMINES dextroamphetamine sulfate er oral capsule extended release 24 hour dextroamphetamine sulfate oral tablet methamphetamine hcl oral tablet VYVANSE ORAL CAPSULE ANOREXIANTS NON-AMPHETAMINE-ANOREXIANTS NON- AMPHETAMINE phentermine hcl oral capsule 15 mg phentermine hcl oral capsule 30 mg QL (180 EA Max Qty Per Fill Retail) QL (90 EA Max Qty Per Fill Retail) phentermine hcl oral tablet QL (90 EA Max Qty Per Fill Retail) ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) AGENTS-ADHD AGENT - SELECTIVE ALPHA ADRENERGIC AGONISTS dexmethylphenidate hcl oral tablet FOCALIN XR ORAL CAPSULE EXTENDED RELEASE 24 HOUR METHYLIN ORAL SOLUTION METHYLIN ORAL TABLET CHEWABLE methylphenidate hcl er (la) oral capsule extended release 24 hour methylphenidate hcl er oral tablet extendedrelease methylphenidate hcl oral solution methylphenidate hcl oral tablet modafinil oral tablet NUVIGIL ORAL TABLET ; ; QL (31 EA per 31 ; ; QL (31 EA per 31 INTUNIV ORAL TABLET EXTENDED RELEASE 24 HR ; QL (31 EA per 31 AMINOGLYCOSIDES AMINOGLYCOSIDES-AMINOGLYCOSIDES QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 14

neomycin sulfate oral tablet diclofenac potassium oral tablet T1 paromomycin sulfate oral capsule streptomycin sulfate intramuscular solution reconstituted diclofenac sodium er oral tablet extended release 24 hr diclofenac sodium oral tablet delayed release ANALGESICS - ANTI-INFLAMMATORY ANTI-TNF-ALPHA - MONOCLONAL ANTIBODIES-ANTI-TNF- ALPHA - MONOCLONAL ANTIBODIES HUMIRA PEN SUBCUTANEOUS ; ; QL (1 EA per 31 HUMIRA PEN-CROHNS STARTER SUBCUTANEOUS HUMIRA PEN-PSORIASIS STARTER SUBCUTANEOUS HUMIRA SUBCUTANEOUS 20 MG/0.4ML, 40 MG/0.8ML GOLD COMPOUNDS-GOLD COMPOUNDS RIDAURA ORAL CAPSULE ; ; QL (1 EA per 365 ; ; QL (1 EA per 365 ; ; QL (1 EA per 31 T5 (SP) INTERLEUKIN-1 BLOCKERS-INTERLEUKIN-1 BLOCKERS ARCALYST SUBCUTANEOUS SOLUTION RECONSTITUTED ; NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS)- CYCLOOXYGENASE 2 (COX-2) INHIBITORS CELEBREX ORAL CAPSULE ST; ; QL (62 EA per 31 celecoxib oral capsule ST; etodolac er oral tablet extended release 24 hr 500 mg, 600 mg etodolac oral capsule etodolac oral tablet fenoprofen calcium oral tablet flurbiprofen oral tablet ibuprofen oral tablet 400 mg, 600 mg, 800 mg indomethacin oral capsule T1 ketoprofen oral capsule ketorolac tromethamine oral tablet meclofenamate sodium oral capsule mefenamic acid oral capsule meloxicam oral suspension meloxicam oral tablet nabumetone oral tablet NAPROSYN ORAL TABLET 375 MG T1 NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS)- NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) naproxen dr oral tablet delayed release 500 mg T1 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 15

naproxen oral tablet T1 SALICYLATES-SALICYLATES naproxen sodium oral tablet 275 mg, 550 mg T1 aspirin low strength oral tablet chewable NCS oxaprozin oral tablet aspirin oral tablet 325 mg NCS piroxicam oral capsule sulindac oral tablet tolmetin sodium oral capsule tolmetin sodium oral tablet PYRIMIDINE SYNTHESIS INHIBITORS-PYRIMIDINE SYNTHESIS INHIBITORS leflunomide oral tablet ; QL (31 EA per 31 SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR AGENTS- SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR AGENTS ENBREL SUBCUTANEOUS ENBREL SUBCUTANEOUS KIT ; ; ; QL (8 EA per 31 diflunisal oral tablet ANALGESICS - OPIOID OPIOID AGONISTS-OPIOID AGONISTS codeine sulfate oral tablet QL (248 EA per 31 fentanyl citrate buccal lollipop fentanyl transdermal patch 72 hr 100 mcg/hr, 12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr QL (15 EA per 31 hydromorphone hcl oral tablet QL (248 EA per 31 levorphanol tartrate oral tablet meperidine hcl oral tablet 50 mg ENBREL SURECLICK SUBCUTANEOUS ; methadone hcl oral tablet QL (248 EA per 31 ANALGESICS - NONNARCOTIC ANALGESIC COMBINATIONS-ANALGESICS-SEDATIVES butalbital-acetaminophen oral tablet butalbital-apap-caffeine oral capsule butalbital-apap-caffeine oral tablet 50-325-40 mg morphine sulfate er oral tablet extendedrelease morphine sulfate oral solution morphine sulfate oral tablet QL (248 EA per 31 NUCYNTA ER ORAL TABLET EXTENDED RELEASE 12 HR NUCYNTA ORAL TABLET PA QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 16

OPANA ER ORAL T5 (SP) QL (61 EA per 31 Days) acetaminophen-codeine #4 oral tablet QL (248 EA per 31 oxycodone hcl oral solution oxycodone hcl oral tablet 10 mg, 20 mg, 5 mg oxycodone hcl oral tablet 15 mg, 30 mg oxymorphone hcl er oral tablet extended release 12 hr QL (248 EA per 31 QL (62 EA per 31 Days) acetaminophen-codeine oral solution butalbital-apap-caff-cod oral capsule butalbital-asa-caff-codeine oral capsule OPIOID COMBINATIONS-HYDROCODONE COMBINATIONS oxymorphone hcl oral tablet tramadol hcl er (biphasic) oral tablet extended release 24 hr 100 mg, 200 mg tramadol hcl er (biphasic) oral tablet extended release 24 hr 300 mg QL (31 EA per 31 Days) QL (31 EA per 31 Days) hydrocodone-acetaminophen oral solution 7.5-325 mg/15ml hydrocodone-acetaminophen oral tablet 10-300 mg, 5-300 mg, 7.5-300 mg hydrocodone-acetaminophen oral tablet 10-325 mg, 7.5-325 mg QL (403 EA per 31 QL (248 EA per 31 tramadol hcl er oral tablet extended release 24 hr 100 mg, 200 mg tramadol hcl er oral tablet extended release 24 hr 300 mg QL (31 EA per 31 Days) QL (31 EA per 31 Days) tramadol hcl oral tablet QL (372 EA per 31 OPIOID COMBINATIONS-CODEINE COMBINATIONS hydrocodone-ibuprofen oral tablet 7.5-200 mg REPREXAIN ORAL TABLET 5-200 MG QL (155 EA per 31 QL (155 EA per 31 OPIOID COMBINATIONS-OPIOID COMBINATIONS oxycodone-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg QL (248 EA per 31 acetaminophen-codeine #2 oral tablet acetaminophen-codeine #3 oral tablet QL (248 EA per 31 QL (248 EA per 31 oxycodone-aspirin oral tablet oxycodone-ibuprofen oral tablet QL (155 EA per 31 OPIOID COMBINATIONS-TRAMADOL COMBINATIONS QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 17

tramadol-acetaminophen oral tablet testosterone cypionate intramuscular solution 100 mg/ml PA OPIOID PARTIAL AGONISTS-OPIOID PARTIAL AGONISTS buprenorphine hcl sublingual tablet sublingual butorphanol tartrate injection solution 2 mg/ml testosterone cypionate intramuscular solution 200 mg/ml testosterone enanthate intramuscular solution ANORECTAL AGENTS PA; PA; BUTRANS TRANSDERMAL PATCH WEEKLY pentazocine-naloxone hcl oral tablet SUBOXONE SUBLINGUAL FILM ANDROGENS-ANABOLIC ANABOLIC STEROIDS-ANABOLIC STEROIDS INTRARECTAL STEROIDS-INTRARECTAL STEROIDS hydrocortisone enema RECTAL COMBINATIONS-RECTAL ANESTHETIC/STEROIDS ANALPRAM ADVANCED COMBINATION KIT hydrocortisone ace-pramoxine cream oxandrolone oral tablet lidocaine-hydrocortisone ace ANDROGENS-ANDROGENS ANDROGEL PUMP TRANSDERMAL 20.25 MG/ACT (1.62%) ANDROGEL TRANSDERMAL 20.25 MG/1.25GM (1.62%) ANDROGEL TRANSDERMAL 25 MG/2.5GM (1%) ANDROGEL TRANSDERMAL 50 MG/5GM (1%) PA; ; QL (300 GM per 31 PA PA; PA; ; QL (300 GM per 31 lidocaine-hydrocortisone ace cream lidocaine-hydrocortisone ace kit PROCORT CREAM PROCTOFOAM HC FOAM RECTAL STEROIDS-RECTAL STEROIDS hydrocortisone acetate suppository PROCTO-PAK CREAM ANDROXY ORAL TABLET PROCTOSOL HC CREAM danazol oral capsule VASODILATING AGENTS-NITRATE VASODILATING AGENTS RECTIV OINTMENT QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 18

ANTHELMINTICS ANTHELMINTICS-ANTHELMINTICS ALBENZA ORAL TABLET BILTRICIDE ORAL TABLET STROMECTOL ORAL TABLET ANTIANGINAL AGENTS ANTIANGINALS-OTHER-ANTIANGINALS-OTHER RANEXA ORAL TABLET EXTENDED RELEASE 12 HR NITRATES-NITRATES isosorbide dinitrate er oral tablet extendedrelease isosorbide dinitrate oral tablet isosorbide mononitrate er oral tablet extended release 24 hr isosorbide mononitrate oral tablet MINITRAN TRANSDERMAL PATCH 24 HR NITRO-BID TRANSDERMAL OINTMENT nitroglycerin transdermal patch 24 hr NITROSTAT SUBLINGUAL TABLET SUBLINGUAL ANTIANXIETY AGENTS ANTIANXIETY AGENTS - MISC.-ANTIANXIETY AGENTS - MISC. buspirone hcl oral tablet hydroxyzine hcl intramuscular solution hydroxyzine hcl oral syrup hydroxyzine hcl oral tablet hydroxyzine pamoate oral capsule meprobamate oral tablet BENZODIAZEPINES-BENZODIAZEPINES alprazolam er oral tablet extended release 24 hr alprazolam oral tablet chlordiazepoxide hcl oral capsule clorazepate dipotassium oral tablet DIAZEPAM INTENSOL ORAL CONCENTRATE diazepam oral solution 1 mg/ml diazepam oral tablet lorazepam oral concentrate lorazepam oral tablet ANTIARRHYTHMICS ANTIARRHYTHMICS TYPE I-A-ANTIARRHYTHMICS TYPE I-A disopyramide phosphate oral capsule NORPACE CR ORAL CAPSULE EXTENDED RELEASE 12 HOUR 150 MG PA QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 19

procainamide hcl injection solution ATROVENT HFA INHALATION AEROSOL, SOLUTION ; QL (26 GM per 31 quinidine gluconate er oral tablet extendedrelease ipratropium bromide inhalation solution quinidine sulfate er oral tablet extendedrelease SPIRIVA HANDIHALER INHALATION CAPSULE ; QL (31 EA per 31 quinidine sulfate oral tablet ANTIARRHYTHMICS TYPE I-C-ANTIARRHYTHMICS TYPE I-C flecainide acetate oral tablet propafenone hcl er oral capsule extended release 12 hour propafenone hcl oral tablet ANTIARRHYTHMICS TYPE III-ANTIARRHYTHMICS TYPE III SPIRIVA RESPIMAT INHALATION AEROSOL, SOLUTION LEUKOTRIENE MODULATORS-5-LIPOXYGENASE INHIBITORS ZYFLO CR ORAL TABLET EXTENDED RELEASE 12 HR ; ; QL (124 EA per 31 LEUKOTRIENE MODULATORS-LEUKOTRIENE RECEPTOR ANTAGONISTS amiodarone hcl oral tablet 200 mg, 400 mg montelukast sodium oral tablet ; QL (31 EA per 31 MULTAQ ORAL TABLET ANTIASTHMATIC AND BRONCHODILATOR AGENTS ANTIASTHMATIC - MONOCLONAL ANTIBODIES-ANTI-IGE MONOCLONAL ANTIBODIES XOLAIR SUBCUTANEOUS SOLUTION RECONSTITUTED ; ANTI-INFLAMMATORY AGENTS-ANTI-INFLAMMATORY AGENTS cromolyn sodium inhalation nebulization solution BRONCHODILATORS - ANTICHOLINERGICS- BRONCHODILATORS - ANTICHOLINERGICS montelukast sodium oral tablet chewable ; QL (31 EA per 31 zafirlukast oral tablet ; QL (62 EA per 31 STEROID INHALANTS-STEROID INHALANTS ASMANEX 120 METERED DOSES INHALATION AEROSOL POWDER, BREATH ACTIVATED ASMANEX 14 METERED DOSES INHALATION AEROSOL POWDER, BREATH ACTIVATED ; QL (1 EA per 31 Days) ; QL (1 EA per 31 Days) QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 20

ASMANEX 30 METERED DOSES INHALATION AEROSOL POWDER, BREATH ACTIVATED ASMANEX 60 METERED DOSES INHALATION AEROSOL POWDER, BREATH ACTIVATED ASMANEX 7 METERED DOSES INHALATION AEROSOL POWDER, BREATH ACTIVATED ASMANEX HFA INHALATION AEROSOL budesonide inhalation suspension ; QL (1 EA per 31 Days) ; QL (1 EA per 31 Days) ; QL (1 EA per 31 Days) ; QL (13 GM per 30 BREO ELLIPTA INHALATION AEROSOL POWDER, BREATH ACTIVATED COMBIVENT RESPIMAT INHALATION AEROSOL, SOLUTION DULERA INHALATION AEROSOL ipratropium-albuterol inhalation solution SYMBICORT INHALATION AEROSOL 160-4.5 MCG/ACT SYMBICORT INHALATION AEROSOL 80-4.5 MCG/ACT ; QL (13 GM per 31 SYMPATHOMIMETICS-BETA ADRENERGICS ST; ; QL (10.2 GM per 31 ST; ; QL (13.8 GM per 31 FLOVENT DISKUS INHALATION AEROSOL POWDER, BREATH ACTIVATED FLOVENT HFA INHALATION AEROSOL ; QL (124 EA per 31 ; QL (24 GM per 31 SYMPATHOMIMETICS-ADRENERGIC COMBINATIONS ADVAIR DISKUS INHALATION AEROSOL POWDER, BREATH ACTIVATED ADVAIR HFA INHALATION AEROSOL ANORO ELLIPTA INHALATION AEROSOL POWDER, BREATH ACTIVATED ; QL (62 EA per 31 ; QL (12 GM per 31 albuterol sulfate inhalation nebulization solution albuterol sulfate oral syrup albuterol sulfate oral tablet ARCAPTA NEOHALER INHALATION CAPSULE BROVANA INHALATION NEBULIZATION SOLUTION levalbuterol hcl inhalation nebulization solution 1.25 mg/0.5ml metaproterenol sulfate oral syrup metaproterenol sulfate oral tablet QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 21

PROVENTIL HFA INHALATION AEROSOL, SOLUTION QL (13.4 GM per 31 Days) XARELTO ORAL TABLET 15 MG, 20 MG PA; SEREVENT DISKUS INHALATION AEROSOL POWDER, BREATH ACTIVATED STRIVERDI RESPIMAT INHALATION AEROSOL, SOLUTION ; QL (62 EA per 31 terbutaline sulfate oral tablet HEPARINS AND HEPARINOID-LIKE AGENTS-HEPARINS AND HEPARINOID-LIKE AGENTS heparin sodium (porcine) injection solution 1000 unit/ml, 10000 unit/ml, 20000 unit/ml, 5000 unit/ml HEPARINS AND HEPARINOID-LIKE AGENTS-LOW MOLECULAR WEIGHT HEPARINS SYMPATHOMIMETICS-MIXED ADRENERGICS epinephrine hcl injection solution 1 mg/ml XANTHINES-XANTHINES aminophylline intravenous solution theophylline er oral tablet extended release 12 hr theophylline er oral tablet extended release 24 hr enoxaparin sodium injection solution enoxaparin sodium subcutaneous solution 100 mg/ml, 150 mg/ml enoxaparin sodium subcutaneous solution 120 mg/0.8ml, 80 mg/0.8ml enoxaparin sodium subcutaneous solution 30 mg/0.3ml T5 (SP) QL (24 ML per 90 Days) T5 (SP) QL (28 ML per 90 Days) T5 (SP) QL (22.4 ML per 90 Days) T5 (SP) QL (8.4 ML per 90 Days) ANTICOAGULANTS COUMARIN ANTICOAGULANTS-COUMARIN ANTICOAGULANTS JANTOVEN ORAL TABLET warfarin sodium oral tablet DIRECT FACTOR XA INHIBITORS-DIRECT FACTOR XA INHIBITORS XARELTO ORAL TABLET 10 MG PA; ; QL (31 EA per 31 enoxaparin sodium subcutaneous solution 40 mg/0.4ml enoxaparin sodium subcutaneous solution 60 mg/0.6ml T5 (SP) QL (11.2 ML per 90 Days) T5 (SP) QL (16.8 ML per 90 Days) HEPARINS AND HEPARINOID-LIKE AGENTS-SYNTHETIC HEPARINOID-LIKE AGENTS fondaparinux sodium subcutaneous solution QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 22

THROMBIN INHIBITORS-THROMBIN INHIBITORS - SELECTIVE DIRECT & REVERSIBLE PRADAXA ORAL CAPSULE ANTICONVULSANTS ANTICONVULSANTS - BENZODIAZEPINES- ANTICONVULSANTS - BENZODIAZEPINES clonazepam oral tablet diazepam ANTICONVULSANTS - MISC.-ANTICONVULSANTS - MISC. BANZEL ORAL SUSPENSION BANZEL ORAL TABLET carbamazepine er oral capsule extended release 12 hour carbamazepine er oral tablet extended release 12 hr ; ; carbamazepine oral suspension carbamazepine oral tablet carbamazepine oral tablet chewable gabapentin oral capsule 100 mg, 300 mg ; QL (372 EA per 31 gabapentin oral capsule 400 mg ; QL (279 EA per 31 gabapentin oral solution ; QL (2232 ML per 31 gabapentin oral tablet 600 mg ; QL (186 EA per 31 gabapentin oral tablet 800 mg ; QL (140 EA per 31 LAMICTAL ODT ORAL KIT LAMICTAL ODT ORAL TABLET DISPERSIBLE lamotrigine oral tablet lamotrigine oral tablet chewable levetiracetam er oral tablet extended release 24 hr 500 mg levetiracetam er oral tablet extended release 24 hr 750 mg levetiracetam oral solution ; QL (93 EA per 31 Days) ; QL (186 EA per 31 ; QL (124 EA per 31 levetiracetam oral tablet 1000 mg ; QL (93 EA per 31 levetiracetam oral tablet 250 mg, 750 mg ; QL (62 EA per 31 levetiracetam oral tablet 500 mg ; QL (186 EA per 31 LYRICA ORAL CAPSULE 100 MG, 150 MG, 200 MG, 25 MG, 50 MG, 75 MG LYRICA ORAL CAPSULE 225 MG, 300 MG oxcarbazepine oral suspension oxcarbazepine oral tablet POTIGA ORAL TABLET ; primidone oral tablet topiramate oral capsule sprinkle ST; ; QL (93 EA per 31 ST; ; QL (62 EA per 31 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 23

topiramate oral tablet VIMPAT ORAL SOLUTION VIMPAT ORAL TABLET zonisamide oral capsule CARBAMATES-CARBAMATES felbamate oral suspension felbamate oral tablet ; ; QL (1240 ML per 31 ; ; QL (62 EA per 31 T5 (SP) T5 (SP) GABA MODULATORS-GABA MODULATORS GABITRIL ORAL TABLET 12 MG, 16 MG, 2 MG T5 (SP) GABITRIL ORAL TABLET 4 MG T5 (SP) ; QL (124 EA per 31 SABRIL ORAL TABLET HYDANTOINS-HYDANTOINS PEGANONE ORAL TABLET divalproex sodium er oral tablet extended release 24 hr divalproex sodium oral capsule sprinkle divalproex sodium oral tablet delayed release valproic acid oral capsule valproic acid oral syrup ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONISTS (TETRACYCLICS)- ALPHA-2 RECEPTOR ANTAGONISTS (TETRACYCLICS) mirtazapine oral tablet 15 mg, 7.5 mg mirtazapine oral tablet 30 mg, 45 mg ; QL (93 EA per 31 ; QL (31 EA per 31 mirtazapine oral tablet dispersible ; QL (31 EA per 31 ANTIDEPRESSANTS - MISC.-ANTIDEPRESSANTS - MISC. phenytoin oral suspension 125 mg/5ml bupropion hcl er (sr) oral tablet extended release 12 hr ; QL (62 EA per 31 phenytoin sodium extended oral capsule bupropion hcl er (xl) oral tablet extended release 24 hr ; QL (31 EA per 31 SUCCINIMIDES-SUCCINIMIDES CELONTIN ORAL CAPSULE ethosuximide oral capsule ethosuximide oral solution VALPROIC ACID-VALPROIC ACID bupropion hcl oral tablet maprotiline hcl oral tablet MONOAMINE OXIDASE INHIBITORS (MAOIS)-MONOAMINE OXIDASE INHIBITORS (MAOIS) EMSAM TRANSDERMAL PATCH 24 HR ; QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 24

MARPLAN ORAL TABLET phenelzine sulfate oral tablet tranylcypromine sulfate oral tablet sertraline hcl oral tablet ; QL (62 EA per 31 SEROTONIN MODULATORS-SEROTONIN MODULATORS BRINTELLIX ORAL TABLET SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)- SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) nefazodone hcl oral tablet 100 mg, 150 mg, 250 mg, 50 mg ; QL (62 EA per 31 citalopram hydrobromide oral solution nefazodone hcl oral tablet 200 mg ; QL (93 EA per 31 citalopram hydrobromide oral tablet trazodone hcl oral tablet 100 mg, 150 mg, 50 mg escitalopram oxalate oral solution trazodone hcl oral tablet 300 mg T1 escitalopram oxalate oral tablet 10 mg, 20 mg ; 1/2 VIIBRYD ORAL KIT T5 (SP) ST; QL (31 EA per 31 escitalopram oxalate oral tablet 5 mg VIIBRYD ORAL TABLET T5 (SP) ST; ; QL (31 EA per 31 fluoxetine hcl oral capsule 10 mg, 20 mg T1 ; QL (93 EA per 31 fluoxetine hcl oral capsule 40 mg T1 ; QL (62 EA per 31 fluoxetine hcl oral solution T1 fluvoxamine maleate oral tablet paroxetine hcl er oral tablet extended release 24 hr paroxetine hcl oral tablet PAXIL ORAL SUSPENSION PEXEVA ORAL TABLET sertraline hcl oral concentrate SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS)-SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) duloxetine hcl oral capsule delayed release particles 20 mg, 60 mg duloxetine hcl oral capsule delayed release particles 30 mg PRISTIQ ORAL TABLET EXTENDED RELEASE 24 HR 100 MG, 50 MG venlafaxine hcl er oral capsule extended release 24 hour 150 mg ; QL (62 EA per 31 Days) ; QL (93 EA per 31 Days) ; QL (31 EA per 31 ; QL (31 EA per 31 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 25

venlafaxine hcl er oral capsule extended release 24 hour 37.5 mg, 75 mg ; QL (93 EA per 31 venlafaxine hcl oral tablet ; QL (93 EA per 31 TRICYCLIC AGENTS-TRICYCLIC AGENTS amitriptyline hcl oral tablet amoxapine oral tablet clomipramine hcl oral capsule desipramine hcl oral tablet doxepin hcl oral capsule doxepin hcl oral concentrate imipramine hcl oral tablet nortriptyline hcl oral capsule protriptyline hcl oral tablet SURMONTIL ORAL CAPSULE TOFRANIL-PM ORAL CAPSULE VIVACTIL ORAL TABLET ANTIDIABETICS ALPHA-GLUCOSIDASE INHIBITORS-ALPHA-GLUCOSIDASE INHIBITORS acarbose oral tablet ; QL (93 EA per 31 GLYSET ORAL TABLET ST; ANTIDIABETIC - AMYLIN ANALOGS-ANTIDIABETIC - AMYLIN ANALOGS SYMLINPEN 120 SUBCUTANEOUS SYMLINPEN 60 SUBCUTANEOUS ANTIDIABETIC COMBINATIONS-DIPEPTIDYL PEPTIDASE-4 INHIBITOR-BIGUANIDE COMBINATIONS JENTADUETO ORAL TABLET ANTIDIABETIC COMBINATIONS-SGL INHIBITOR - DPP-4 INHIBITOR COMBINATIONS GLYXAMBI ORAL TABLET ANTIDIABETIC COMBINATIONS-SULFONYLUREA-BIGUANIDE COMBINATIONS glipizide-metformin hcl oral tablet 2.5-250 mg glipizide-metformin hcl oral tablet 2.5-500 mg, 5-500 mg glyburide-metformin oral tablet 1.25-250 mg glyburide-metformin oral tablet 2.5-500 mg, 5-500 mg ; QL (248 EA per 31 ; QL (124 EA per 31 ; QL (248 EA per 31 ; QL (124 EA per 31 ANTIDIABETIC COMBINATIONS-SULFONYLUREA- THIAZOLIDINEDIONE COMBINATIONS pioglitazone hcl-glimepiride oral tablet BIGUANIDES-BIGUANIDES metformin hcl er (osm) oral tablet extended release 24 hr 1000 mg metformin hcl er (osm) oral tablet extended release 24 hr 500 mg ; QL (31 EA per 31 ST; ; QL (62 EA per 31 ST; ; QL (155 EA per 31 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 26

metformin hcl er oral tablet extended release 24 hr 500 mg metformin hcl er oral tablet extended release 24 hr 750 mg ; QL (124 EA per 31 ; QL (62 EA per 31 metformin hcl oral tablet 1000 mg T1 ; QL (62 EA per 31 metformin hcl oral tablet 500 mg T1 ; QL (155 EA per 31 metformin hcl oral tablet 850 mg T1 ; QL (93 EA per 31 DIABETIC OTHER-DIABETIC OTHER GLUCAGEN HYPOKIT INJECTION SOLUTION RECONSTITUTED GLUCAGON EMERGENCY INJECTION KIT PROGLYCEM ORAL SUSPENSION DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS TRADJENTA ORAL TABLET DOPAMINE RECEPTOR AGONISTS - ANTIDIABETIC- DOPAMINE RECEPTOR AGONISTS - ERGOT DERIVATIVES CYCLOSET ORAL TABLET ST; BYDUREON SUBCUTANEOUS SUSPENSION RECONSTITUTED BYETTA 10 MCG PEN SUBCUTANEOUS BYETTA 5 MCG PEN SUBCUTANEOUS TANZEUM SUBCUTANEOUS ; QL (4.8 ML per 31 ; QL (4.8 ML per 31 INSULIN SENSITIZING AGENTS-THIAZOLIDINEDIONES AVANDIA ORAL TABLET ST; pioglitazone hcl oral tablet INSULIN-HUMAN INSULIN HUMULIN R U-500 (CONCENTRATED) SUBCUTANEOUS SOLUTION LEVEMIR FLEXPEN SUBCUTANEOUS LEVEMIR FLEXTOUCH SUBCUTANEOUS LEVEMIR SUBCUTANEOUS SOLUTION NOVOLIN 70/30 SUBCUTANEOUS SUSPENSION T5 (SP) ; QL (20 ML per 28 ; QL (60 ML per 31 ; QL (60 ML per 31 ; QL (60 ML per 31 ; QL (60 ML per 31 INCRETIN MIMETIC AGENTS (GLP-1 RECEPTOR AGONISTS)- INCRETIN MIMETIC AGENTS (GLP-1 RECEPTOR AGONISTS) BYDUREON SUBCUTANEOUS NOVOLIN N SUBCUTANEOUS SUSPENSION NOVOLIN R INJECTION SOLUTION ; QL (60 ML per 31 ; QL (60 ML per 31 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 27

NOVOLOG FLEXPEN SUBCUTANEOUS ; QL (60 ML per 31 glipizide er oral tablet extended release 24 hr 10 mg ; QL (62 EA per 31 NOVOLOG MIX 70/30 FLEXPEN SUBCUTANEOUS ; QL (60 ML per 31 glipizide er oral tablet extended release 24 hr 2.5 mg ; QL (248 EA per 31 NOVOLOG MIX 70/30 SUBCUTANEOUS SUSPENSION NOVOLOG PENFILL SUBCUTANEOUS NOVOLOG SUBCUTANEOUS SOLUTION ; QL (60 ML per 31 ; QL (60 ML per 31 ; QL (60 ML per 31 MEGLITINIDE ANALOGUES-MEGLITINIDE ANALOGUES glipizide er oral tablet extended release 24 hr 5 mg ; QL (124 EA per 31 glipizide oral tablet 10 mg T1 ; QL (124 EA per 31 glipizide oral tablet 5 mg T1 ; QL (248 EA per 31 GLIPIZIDE XL ORAL TABLET EXTENDED RELEASE 24 HR nateglinide oral tablet ; QL (93 EA per 31 repaglinide oral tablet ; QL (93 EA per 31 Days) glyburide micronized oral tablet 1.5 mg, 3 mg glyburide micronized oral tablet 6 mg ; QL (124 EA per 31 ; QL (62 EA per 31 SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGL) INHIBITORS-SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGL) INHIBITORS JARDIANCE ORAL TABLET SULFONYLUREAS-SULFONYLUREAS chlorpropamide oral tablet glimepiride oral tablet 1 mg ; QL (248 EA per 31 glimepiride oral tablet 2 mg ; QL (124 EA per 31 glimepiride oral tablet 4 mg ; QL (62 EA per 31 glyburide oral tablet 1.25 mg ; QL (496 EA per 31 glyburide oral tablet 2.5 mg ; QL (248 EA per 31 glyburide oral tablet 5 mg ; QL (124 EA per 31 tolazamide oral tablet ST; tolbutamide oral tablet ST; ANTIDIARRHEALS ANTIPERISTALTIC AGENTS-ANTIPERISTALTIC AGENTS diphenatol oral tablet QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 28

diphenoxylate-atropine oral liquid ANTIEMETICS - ANTICHOLINERGIC-ANTIEMETICS - ANTICHOLINERGIC diphenoxylate-atropine oral tablet meclizine hcl oral tablet loperamide hcl oral capsule MOTOFEN ORAL TABLET ANTIDOTES ANTIDOTES - CHELATING AGENTS-ANTIDOTES - CHELATING AGENTS CHEMET ORAL CAPSULE EXJADE ORAL TABLET SOLUBLE FERRIPROX ORAL TABLET ; OPIOID ANTAGONISTS-OPIOID ANTAGONISTS naltrexone hcl oral tablet ANTIEMETICS 5-H RECEPTOR ANTAGONISTS-5-H RECEPTOR ANTAGONISTS ANZEMET ORAL TABLET 50 MG granisetron hcl oral tablet GRANISOL ORAL SOLUTION ondansetron hcl oral solution ondansetron hcl oral tablet 24 mg QL (31 EA per 31 ondansetron hcl oral tablet 4 mg, 8 mg ondansetron oral tablet dispersible QL (62 EA per 31 TIGAN INTRAMUSCULAR SOLUTION trimethobenzamide hcl oral capsule PA ANTIEMETICS - MISCELLANEOUS-ANTIEMETICS - MISCELLANEOUS CESAMET ORAL CAPSULE dronabinol oral capsule ; QL (62 EA per 31 SUBSTANCE P/NEUROKININ 1 (NK1) RECEPTOR ANTAGONISTS-SUBSTANCE P/NEUROKININ 1 (NK1) RECEPTOR ANTAGONISTS EMEND ORAL CAPSULE PA; QL (62 EA per 31 ANTIFUNGALS ANTIFUNGALS-ANTIFUNGALS flucytosine oral capsule griseofulvin microsize oral suspension nystatin oral tablet T5 (SP) terbinafine hcl oral tablet QL (31 EA per 31 IMIDAZOLE-RELATED ANTIFUNGALS-IMIDAZOLES ketoconazole oral tablet IMIDAZOLE-RELATED ANTIFUNGALS-TRIAZOLES QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 29

fluconazole oral tablet itraconazole oral capsule PA NOXAFIL ORAL SUSPENSION voriconazole oral tablet ANTIHISTAMINES promethazine hcl oral tablet 50 mg promethazine hcl suppository 12.5 mg, 25 mg PROMETHEGAN SUPPOSITORY ANTIHISTAMINES - ETHANOLAMINES-ANTIHISTAMINES - ETHANOLAMINES carbinoxamine maleate oral tablet clemastine fumarate oral syrup clemastine fumarate oral tablet 2.68 mg diphenhydramine hcl injection solution ANTIHISTAMINES - NON-SEDATING-ANTIHISTAMINES - NON- SEDATING levocetirizine dihydrochloride oral solution levocetirizine dihydrochloride oral tablet ANTIHISTAMINES - PHENOTHIAZINES-ANTIHISTAMINES - PHENOTHIAZINES promethazine hcl injection solution 25 mg/ml promethazine hcl oral syrup promethazine hcl oral tablet 12.5 mg, 25 mg T1 ANTIHISTAMINES - PIPERIDINES-ANTIHISTAMINES - PIPERIDINES cyproheptadine hcl oral tablet ANTIHYPERLIPIDEMICS ANTIHYPERLIPIDEMICS - COMBINATIONS-INTEST CHOLEST ABSORP INHIB-HMG COA REDUCTASE INHIB COMB LIPTRUZET ORAL TABLET ; QL (93 EA per 31 Days) VYTORIN ORAL TABLET ANTIHYPERLIPIDEMICS - MISC.-ANTIHYPERLIPIDEMICS - MISC. LOVAZA ORAL CAPSULE VASCEPA ORAL CAPSULE BILE ACID SEQUESTRANTS-BILE ACID SEQUESTRANTS cholestyramine light oral packet cholestyramine light oral powder cholestyramine oral packet cholestyramine oral powder colestipol hcl oral granules colestipol hcl oral tablet PREVALITE ORAL PACKET T1 QL Quantity Limit applies SP Specialty Pharmacy Maintenance Drug 2015 Commercial/TPA 5 Tier Formulary Version 1 Page 30